Overview
Redcare Pharmacy NV is a company based in the Netherlands, primarily operating within the pharmaceutical sector. It specializes in retailing a wide range of medications and health-related products, and also offers pharmaceutical services to customers. Key projects typically involve leveraging advanced technology to improve the efficiency of their service delivery and expanding their reach through e-commerce platforms. These initiatives aim to enhance customer accessibility to pharmaceutical services and cater to the growing demand for health products. Redcare Pharmacy NV continuously focuses on integrating innovative solutions that optimize operational efficiency and customer satisfaction, sustaining its competitive edge in the fast-evolving healthcare market.
AI+ Ask Fintel’s AI assistant about Redcare Pharmacy NV.
Thinking about good questions…
Basic Stats
The share price of Redcare Pharmacy NV as of September 5, 2025 is €108.20 / share. This is a decrease of 0.00% from the prior week. The market cap (or net worth) of Redcare Pharmacy NV as of September 5, 2025 is €2,201.06 MM.
The Factor Analysis chart (below right) shows a view of Redcare Pharmacy NV from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 2,201.06 MM |
| EV | 2,510.99 MM |
| Shares Out. | 20.34 MM |
| Earnings Date | |
| EPS (TTM) | -1.71 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | 0.29 |
| Beta | -0.33 |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | -63.15 |
| Price/Book | 4.16 |
| Price/TBV | 21.16 |
| Book/Market | 0.24 |
| EBIT/EV | -0.02 |
| EBIT(3yr avg)/EV | -0.01 |
| ROA | -0.03 |
| ROE | -0.06 |
| ROIC | -0.04 |
| CROIC | -0.02 |
| OCROIC | 0.05 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 61.80 /100 |
| Profitability | 31.89 /100 |
| Quality Score | 53.55 /100 |
| Value Score | 26.54 /100 |
| Momentum Score | |
| Stability (Low Vol) Score | 75.22 /100 |
| Analyst Sentiment | |
| Fund Sentiment | 29.95 /100 |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 5.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Redcare Pharmacy NV. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2025-04-06 | BAADER HELVEA EQUITY RESEARCH | Buy | Buy | Maintains |
| 2025-04-03 | STIFEL EUROPE | Buy | Buy | Maintains |
| 2025-04-03 | METZLER EQUITIES | Buy | Buy | Maintains |
| 2025-04-03 | WARBURG RESEARCH GMBH | Buy | Buy | Maintains |
| 2025-04-02 | JEFFERIES | Buy | Buy | Maintains |
| 2025-03-31 | BERENBERG | Buy | Buy | Maintains |
| 2025-03-23 | HSBC | Buy | Buy | Maintains |
| 2025-03-10 | HAUCK AUFHAEUSER INVESTMENT BANKING | Buy | Buy | Maintains |
| 2025-01-23 | MWB RESEARCH AG | Hold | Buy | Upgrade |
| 2025-01-03 | METZLER EQUITIES | Buy | Buy | Maintains |
| 2024-12-18 | HAUCK AUFHAEUSER INVESTMENT BANKING | Buy | Buy | Maintains |
| 2024-11-28 | BERENBERG | Buy | Buy | Maintains |
| 2024-11-24 | HSBC | Hold | Buy | Upgrade |
| 2024-11-06 | STIFEL EUROPE | Buy | Buy | Maintains |
| 2024-11-05 | MWB RESEARCH AG | Hold | Hold | Maintains |
| 2024-11-04 | BAADER HELVEA EQUITY RESEARCH | Buy | Buy | Maintains |
| 2024-11-04 | WARBURG RESEARCH GMBH | Buy | Buy | Maintains |
| 2024-08-25 | HSBC | Hold | Hold | Maintains |
| 2024-08-06 | STIFEL EUROPE | Buy | Buy | Maintains |
| 2024-07-30 | MWB RESEARCH AG | Sell | Hold | Upgrade |
| 2024-07-30 | BERENBERG | Hold | Buy | Upgrade |
| 2024-07-30 | METZLER EQUITIES | Hold | Buy | Upgrade |
| 2024-07-30 | HAUCK AUFHAEUSER INVESTMENT BANKING | Buy | Buy | Maintains |
| 2024-07-29 | BAADER HELVEA EQUITY RESEARCH | Buy | Buy | Maintains |
| 2024-07-29 | WARBURG RESEARCH GMBH | Hold | Buy | Upgrade |
| 2024-05-26 | HSBC | Hold | Hold | Maintains |
| 2024-04-24 | MWB RESEARCH AG | Buy | Sell | Downgrade |
| 2024-04-24 | WARBURG RESEARCH GMBH | Buy | Hold | Downgrade |
| 2024-01-02 | BERENBERG | Hold | Hold | Maintains |
| 2023-12-13 | BAADER HELVEA EQUITY RESEARCH | Buy | Buy | Maintains |
| 2023-12-12 | BAADER HELVEA EQUITY RESEARCH | Buy | Buy | Maintains |
| 2023-11-22 | SRH ALSTERRESEARCH AG | Hold | Buy | Upgrade |
| 2023-11-21 | MWB RESEARCH AG | Buy | Buy | Maintains |
| 2023-11-21 | SRH ALSTERRESEARCH AG | Hold | Buy | Upgrade |
| 2023-11-01 | METZLER EQUITIES | Hold | Hold | Maintains |
| 2023-11-01 | HAUCK AUFHAEUSER INVESTMENT BANKING | Buy | Buy | Maintains |
| 2023-11-01 | WARBURG RESEARCH GMBH | Buy | Buy | Maintains |
| 2023-10-31 | METZLER EQUITIES | Hold | Hold | Maintains |
| 2023-10-31 | HAUCK AUFHAEUSER INVESTMENT BANKING | Buy | Buy | Maintains |
| 2023-10-31 | WARBURG RESEARCH GMBH | Buy | Buy | Maintains |
| 2023-08-23 | SRH ALSTERRESEARCH AG | Buy | Hold | Downgrade |
| 2023-08-22 | SRH ALSTERRESEARCH AG | Buy | Hold | Downgrade |
| 2023-08-22 | BERENBERG | Hold | Hold | Maintains |
| 2023-08-21 | BERENBERG | Hold | Hold | Maintains |
| 2023-08-21 | WARBURG RESEARCH GMBH | Buy | Buy | Maintains |
| 2023-08-20 | WARBURG RESEARCH GMBH | Buy | Buy | Maintains |
| 2023-08-02 | HAUCK AUFHAEUSER INVESTMENT BANKING | Buy | Buy | Maintains |
| 2023-08-02 | CREDIT SUISSE - EUROPE | Underperform | Underperform | Maintains |
| 2023-08-01 | HAUCK AUFHAEUSER INVESTMENT BANKING | Buy | Buy | Maintains |
| 2023-08-01 | CREDIT SUISSE - EUROPE | Underperform | Underperform | Maintains |
| 2023-08-01 | BAADER HELVEA EQUITY RESEARCH | Buy | Buy | Maintains |
| 2023-07-31 | BAADER HELVEA EQUITY RESEARCH | Buy | Buy | Maintains |
| 2023-07-07 | METZLER EQUITIES | Hold | Hold | Maintains |
| 2023-07-06 | METZLER EQUITIES | Hold | Hold | Maintains |
| 2023-07-06 | SRH ALSTERRESEARCH AG | Buy | Buy | Maintains |
| 2023-07-05 | SRH ALSTERRESEARCH AG | Buy | Buy | Maintains |
| 2023-05-22 | HSBC | Hold | Hold | Maintains |
| 2023-05-21 | HSBC | Hold | Hold | Maintains |
| 2025-07-17 | METZLER EQUITIES | Buy | Buy | Maintains |
| 2025-07-16 | JEFFERIES | Buy | Buy | Maintains |
| 2025-07-02 | BAADER HELVEA EQUITY RESEARCH | Buy | Buy | Maintains |
| 2025-06-30 | BERENBERG | Buy | Buy | Maintains |
| 2025-05-25 | HSBC | Buy | Buy | Maintains |
| 2025-05-06 | MWB RESEARCH AG | Buy | Buy | Maintains |
| 2025-05-06 | HAUCK AUFHAEUSER INVESTMENT BANKING | Buy | Buy | Maintains |
| 2025-05-05 | WARBURG RESEARCH GMBH | Buy | Buy | Maintains |
